Cargando…
Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage
Autores principales: | Laurencet, Marie-Eva, Iglesias, Juan F., Noble, Stéphane, Tessitore, Elena, Degrauwe, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078953/ https://www.ncbi.nlm.nih.gov/pubmed/33881772 http://dx.doi.org/10.5603/CJ.2021.0032 |
Ejemplares similares
-
Pancreatic Pseudocyst Hemorrhage Complicated by an Acute ST-Elevation Myocardial Infarction
por: Groudan, Kevin, et al.
Publicado: (2021) -
Comparative effects of fentanyl versus morphine on platelet inhibition induced by ticagrelor in patients with ST-segment elevation myocardial infarction: Full results of the PERSEUS randomized trial
por: Iglesias, Juan F., et al.
Publicado: (2022) -
Analysis of subconjunctival hemorrhage
por: Sahinoglu-Keskek, Nedime, et al.
Publicado: (2013) -
Myocardial Infarction in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report and Review of Literature
por: Rao, Suman, et al.
Publicado: (2021) -
Dual antiplatelet therapy for secondary prevention of coronary artery disease
por: Degrauwe, Sophie, et al.
Publicado: (2017)